A prospective cluster trial to increase antibiotic prescription quality in seven non-ICU wards.

IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Simone Scheithauer, Britta Karasimos, David Manamayil, Helga Häfner, Karl Lewalter, Karl Mischke, Bernhard Heintz, Frank Tacke, David Brücken, Christian Lüring, Christoph Heidenhain, Lachmandath Tewarie, Ralf-Dieter Hilgers, Sebastian W Lemmen
{"title":"A prospective cluster trial to increase antibiotic prescription quality in seven non-ICU wards.","authors":"Simone Scheithauer,&nbsp;Britta Karasimos,&nbsp;David Manamayil,&nbsp;Helga Häfner,&nbsp;Karl Lewalter,&nbsp;Karl Mischke,&nbsp;Bernhard Heintz,&nbsp;Frank Tacke,&nbsp;David Brücken,&nbsp;Christian Lüring,&nbsp;Christoph Heidenhain,&nbsp;Lachmandath Tewarie,&nbsp;Ralf-Dieter Hilgers,&nbsp;Sebastian W Lemmen","doi":"10.3205/dgkh000440","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate general shortcomings and faculty-specific pitfalls as well as to improve antibiotic prescription quality (ABQ) in non-ICU wards, we performed a prospective cluster trial.</p><p><strong>Methods: </strong>An infectious-disease (ID) consulting service performed a prospective investigation consisting of three 12-week phases with point prevalence evaluation conducted once per week (=36 evaluations in total) at seven non-ICU wards, followed by assessment of sustainability (weeks 37-48). Baseline evaluation (phase 1) defined multifaceted interventions by identifying the main shortcomings. Then, to distinguish intervention from time effects, the interventions were performed in four wards, and the 3 remaining wards served as controls; after assessing effects (phase 2), the same interventions were performed in the remaining wards to test the generalizability of the interventions (phase 3). The prolonged responses after all interventions were then analyzed in phase 4. ABQ was evaluated by at least two ID specialists who assessed the indication for therapy, the adherence to the hospital guidelines for empirical therapy, and the overall antibiotic prescription quality.</p><p><strong>Results: </strong>In phase 1, 406 of 659 (62%) patients cases were adequately treated with antibiotics; the main reason for inappropriate prescription was the lack of an indication (107/253; 42%). The antibiotic prescription quality (ABQ) significantly increased, reaching 86% in all wards after the focused interventions (502/584; nDf=3, ddf=1,697, F=6.9, p=0.0001). In phase 2 the effect was only seen in wards that already participated in interventions (248/347; 71%). No improvement was seen in wards that received interventions only after phase 2 (189/295; 64%). A given indication significantly increased from about 80% to more than 90% (p<.0001). No carryover effects were observed.</p><p><strong>Discussion: </strong>ABQ can be improved significantly by intervention bundles with apparent sustainable effects.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"18 ","pages":"Doc14"},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316282/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS Hygiene and Infection Control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/dgkh000440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To evaluate general shortcomings and faculty-specific pitfalls as well as to improve antibiotic prescription quality (ABQ) in non-ICU wards, we performed a prospective cluster trial.

Methods: An infectious-disease (ID) consulting service performed a prospective investigation consisting of three 12-week phases with point prevalence evaluation conducted once per week (=36 evaluations in total) at seven non-ICU wards, followed by assessment of sustainability (weeks 37-48). Baseline evaluation (phase 1) defined multifaceted interventions by identifying the main shortcomings. Then, to distinguish intervention from time effects, the interventions were performed in four wards, and the 3 remaining wards served as controls; after assessing effects (phase 2), the same interventions were performed in the remaining wards to test the generalizability of the interventions (phase 3). The prolonged responses after all interventions were then analyzed in phase 4. ABQ was evaluated by at least two ID specialists who assessed the indication for therapy, the adherence to the hospital guidelines for empirical therapy, and the overall antibiotic prescription quality.

Results: In phase 1, 406 of 659 (62%) patients cases were adequately treated with antibiotics; the main reason for inappropriate prescription was the lack of an indication (107/253; 42%). The antibiotic prescription quality (ABQ) significantly increased, reaching 86% in all wards after the focused interventions (502/584; nDf=3, ddf=1,697, F=6.9, p=0.0001). In phase 2 the effect was only seen in wards that already participated in interventions (248/347; 71%). No improvement was seen in wards that received interventions only after phase 2 (189/295; 64%). A given indication significantly increased from about 80% to more than 90% (p<.0001). No carryover effects were observed.

Discussion: ABQ can be improved significantly by intervention bundles with apparent sustainable effects.

提高7个非icu病房抗生素处方质量的前瞻性集群试验。
目的:为了评估非icu病房的普遍缺陷和教师特定缺陷,以及提高抗生素处方质量(ABQ),我们进行了一项前瞻性集群试验。方法:传染病(ID)咨询服务在7个非icu病房进行前瞻性调查,包括3个12周的阶段,每周进行1次点患病率评估(共36次评估),随后进行可持续性评估(37-48周)。基线评估(第一阶段)通过确定主要缺点确定了多方面的干预措施。然后,为了区分干预和时间效应,在4个病房进行干预,其余3个病房作为对照;在评估效果(第2阶段)后,在其余病房进行相同的干预,以测试干预的普遍性(第3阶段)。然后在第4阶段分析所有干预后的长期反应。ABQ由至少两名ID专家评估,他们评估治疗的适应症、对医院经验性治疗指南的依从性以及整体抗生素处方质量。结果:在第1期,659例患者中有406例(62%)得到了充分的抗生素治疗;处方不当的主要原因是缺乏指征(107/253;42%)。重点干预后,各病房抗生素处方质量(ABQ)均显著提高,达到86% (502/584;nDf=3, ddf= 1697, F=6.9, p=0.0001)。在第二阶段,效果只在已经参与干预的病房中看到(248/347;71%)。仅在第2期后接受干预的病房没有改善(189/295;64%)。某一特定适应症从约80%显著增加到90%以上(p讨论:ABQ可通过具有明显可持续效果的干预组合得到显著改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
GMS Hygiene and Infection Control
GMS Hygiene and Infection Control PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
自引率
0.00%
发文量
12
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信